{"downloaded": true, "htmlmade": false, "full": {"id": "30741685", "source": "MED", "pmid": "30741685", "pmcid": "PMC6597965", "fullTextIdList": {"fullTextId": "PMC6597965"}, "doi": "10.3233/jpd-181515", "title": "One Step Into the Future: New iPSC Tools to Advance Research in Parkinson's Disease and Neurological Disorders.", "authorString": "Mohamed NV, Larroquette F, Beitel LK, Fon EA, Durcan TM.", "authorList": {"author": [{"fullName": "Mohamed NV", "firstName": "Nguyen-Vi", "lastName": "Mohamed", "initials": "NV", "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "Department of Neurology and Neurosurgery, Montreal Neurological Institute, McGill University, Montreal, QC, Canada."}}}, {"fullName": "Larroquette F", "firstName": "Fr\u00e9d\u00e9rique", "lastName": "Larroquette", "initials": "F", "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "Department of Neurology and Neurosurgery, Montreal Neurological Institute, McGill University, Montreal, QC, Canada."}}}, {"fullName": "Beitel LK", "firstName": "Lenore K", "lastName": "Beitel", "initials": "LK", "authorId": {"@type": "ORCID", "#text": "0000-0002-2836-5568"}, "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "Department of Neurology and Neurosurgery, Montreal Neurological Institute, McGill University, Montreal, QC, Canada."}}}, {"fullName": "Fon EA", "firstName": "Edward A", "lastName": "Fon", "initials": "EA", "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "Department of Neurology and Neurosurgery, Montreal Neurological Institute, McGill University, Montreal, QC, Canada."}}}, {"fullName": "Durcan TM", "firstName": "Thomas M", "lastName": "Durcan", "initials": "TM", "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "Department of Neurology and Neurosurgery, Montreal Neurological Institute, McGill University, Montreal, QC, Canada."}}}]}, "authorIdList": {"authorId": {"@type": "ORCID", "#text": "0000-0002-2836-5568"}}, "dataLinksTagsList": {"dataLinkstag": "altmetrics"}, "journalInfo": {"issue": "2", "volume": "9", "journalIssueId": "2820165", "dateOfPublication": "2019", "monthOfPublication": "0", "yearOfPublication": "2019", "printPublicationDate": "2019-01-01", "journal": {"title": "Journal of Parkinson's disease", "ISOAbbreviation": "J Parkinsons Dis", "medlineAbbreviation": "J Parkinsons Dis", "NLMid": "101567362", "ISSN": "1877-7171", "ESSN": "1877-718X"}}, "pubYear": "2019", "pageInfo": "265-281", "abstractText": "Studying Parkinson's disease (PD) in the laboratory presents many challenges, the main one being the limited availability of human cells and tissue from affected individuals. As PD is characterized by a loss of dopaminergic (DA) neurons in the brain, it is nearly impossible for researchers to access and extract these cells from living patients. Thus, in the past PD research has focused on the use of patients' post-mortem tissues, animal models, or immortalized cell lines to dissect cellular pathways of interest. While these strategies deepened our knowledge of pathological mechanisms in PD, they failed to faithfully capture key mechanisms at play in the human brain. The emergence of induced pluripotent stem cell (iPSC) technology is revolutionizing PD research, as it allows for the differentiation and growth of human DA neurons in vitro, holding immense potential not only for modelling PD, but also for identifying novel therapies. However, to reproduce the complexity of the brain's environment, researchers are recognizing the need to further develop and refine iPSC-based tools. In this review, we provide an overview of different systems now available for the study of PD, with a particular emphasis on the potential and limitations of iPSC as research tools to generate more relevant models of PD pathophysiology and advance the drug discovery process.", "affiliation": "Department of Neurology and Neurosurgery, Montreal Neurological Institute, McGill University, Montreal, QC, Canada.", "publicationStatus": "ppublish", "language": "eng", "pubModel": "Print", "pubTypeList": {"pubType": ["Research Support, Non-U.S. Gov't", "review-article", "Review", "Journal Article"]}, "meshHeadingList": {"meshHeading": [{"majorTopic_YN": "N", "descriptorName": "Organoids"}, {"majorTopic_YN": "N", "descriptorName": "Humans"}, {"majorTopic_YN": "Y", "descriptorName": "Parkinson Disease"}, {"majorTopic_YN": "N", "descriptorName": "Coculture Techniques"}, {"majorTopic_YN": "N", "descriptorName": "Biomedical Research"}, {"majorTopic_YN": "N", "descriptorName": "Drug Discovery"}, {"majorTopic_YN": "N", "descriptorName": "Lab-On-A-Chip Devices"}, {"majorTopic_YN": "Y", "descriptorName": "Induced Pluripotent Stem Cells"}, {"majorTopic_YN": "N", "descriptorName": "CRISPR-Cas Systems"}, {"majorTopic_YN": "N", "descriptorName": "In Vitro Techniques"}, {"majorTopic_YN": "N", "descriptorName": "Gene Editing"}]}, "keywordList": {"keyword": ["Cell therapy", "Stem Cells", "Parkinson\u2019s Disease", "Crispr", "Co-cultures", "Neuronal Organoids"]}, "subsetList": {"subset": {"code": "IM", "name": "Index Medicus"}}, "fullTextUrlList": {"fullTextUrl": [{"availability": "Subscription required", "availabilityCode": "S", "documentStyle": "doi", "site": "DOI", "url": "https://doi.org/10.3233/JPD-181515"}, {"availability": "Open access", "availabilityCode": "OA", "documentStyle": "html", "site": "Europe_PMC", "url": "https://europepmc.org/articles/PMC6597965"}, {"availability": "Open access", "availabilityCode": "OA", "documentStyle": "pdf", "site": "Europe_PMC", "url": "https://europepmc.org/articles/PMC6597965?pdf=render"}]}, "isOpenAccess": "Y", "inEPMC": "Y", "inPMC": "N", "hasPDF": "Y", "hasBook": "N", "hasSuppl": "N", "citedByCount": "0", "hasData": "N", "hasReferences": "Y", "hasTextMinedTerms": "Y", "hasDbCrossReferences": "N", "hasLabsLinks": "Y", "license": "cc by-nc", "authMan": "N", "epmcAuthMan": "N", "nihAuthMan": "N", "hasTMAccessionNumbers": "N", "dateOfCompletion": "2020-04-27", "dateOfCreation": "2019-02-12", "firstIndexDate": "2019-02-11", "fullTextReceivedDate": "2020-07-12", "dateOfRevision": "2020-04-27", "firstPublicationDate": "2019-01-01"}, "htmllinks": "https://europepmc.org/articles/PMC6597965", "abstract": "Studying Parkinson's disease (PD) in the laboratory presents many challenges, the main one being the limited availability of human cells and tissue from affected individuals. As PD is characterized by a loss of dopaminergic (DA) neurons in the brain, it is nearly impossible for researchers to access and extract these cells from living patients. Thus, in the past PD research has focused on the use of patients' post-mortem tissues, animal models, or immortalized cell lines to dissect cellular pathways of interest. While these strategies deepened our knowledge of pathological mechanisms in PD, they failed to faithfully capture key mechanisms at play in the human brain. The emergence of induced pluripotent stem cell (iPSC) technology is revolutionizing PD research, as it allows for the differentiation and growth of human DA neurons in vitro, holding immense potential not only for modelling PD, but also for identifying novel therapies. However, to reproduce the complexity of the brain's environment, researchers are recognizing the need to further develop and refine iPSC-based tools. In this review, we provide an overview of different systems now available for the study of PD, with a particular emphasis on the potential and limitations of iPSC as research tools to generate more relevant models of PD pathophysiology and advance the drug discovery process.", "Keywords": ["Cell therapy", "Stem Cells", "Parkinson\u2019s Disease", "Crispr", "Co-cultures", "Neuronal Organoids"], "pdflinks": "https://europepmc.org/articles/PMC6597965?pdf=render", "journaltitle": "Journal of Parkinson's disease", "authorinfo": ["Mohamed NV", "Larroquette F", "Beitel LK", "Fon EA", "Durcan TM"], "title": "One Step Into the Future: New iPSC Tools to Advance Research in Parkinson's Disease and Neurological Disorders."}